Theralase Technologies Inc.
TLTFF
Rank in Stocks
#23488
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages... Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Share Price
$0.1306
Last synced: 2026-11-09
Market Cap
$41.77M
Change (1 day)
0.46%
Change (1 year)
-12.93%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Theralase Technologies Inc. (TLTFF)
Category
Healthcare
Operating Margin for Theralase Technologies Inc. (TLTFF)
Operating Margin as of November 2026 TTM: -474.33%
According to Theralase Technologies Inc.'s latest financial reports, its current operating margin (TTM) is -474.33%. At the end of 2025 the company had an operating margin of -511.39%.
Operating Margin history for Theralase Technologies Inc. from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -474.33% | -7.25% |
| 2025 | -511.39% | 23.24% |
| 2024 | -414.96% | -3.33% |
| 2023 | -429.25% | -6.03% |
| 2022 | -456.79% | -21.09% |
| 2021 | -578.87% | -3.84% |
| 2020 | -601.97% | -21.43% |
| 2019 | -766.20% | 294.58% |
| 2018 | -194.18% | -25.24% |
| 2017 | -259.75% | -201.28% |
| 2016 | 256.46% | -4.21% |
| 2015 | 267.74% | 43.47% |
| 2014 | 186.62% | 103.49% |
| 2013 | 91.71% | 10.83% |
| 2012 | 82.75% | -214.83% |
| 2011 | -72.06% | -222.22% |
| 2010 | 58.96% | 475.22% |
| 2009 | 10.25% | -80.00% |
| 2008 | 51.24% | -26.97% |
| 2007 | 70.16% | 250.27% |
| 2006 | 20.03% | 1,923.23% |
| 2005 | 0.99% | -89.46% |
| 2004 | 9.39% | -95.15% |
| 2003 | 193.65% | -90.74% |
| 2002 | 2,091.28% | 0.00% |
| 2001 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.03% |
US
|
|
| 18.08% | -100.04% |
IE
|
|
| 21.25% | -100.04% |
US
|
|
| 21.05% | -100.04% |
US
|
|
| 28.09% | -100.06% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Theralase Technologies Inc.'s operating margin
What is Theralase Technologies Inc.'s operating margin?
Theralase Technologies Inc.'s operating margin is -474.33%, as of Nov 2026.
What was Theralase Technologies Inc.'s operating margin in 2025?
In 2025, Theralase Technologies Inc.'s operating margin was -511.39%, compared with -414.96% in 2024.
How has Theralase Technologies Inc.'s operating margin changed since 2020?
From 2020 to 2025, Theralase Technologies Inc.'s operating margin was highest in 2024 (-414.96%) and lowest in 2020 (-601.97%).
How does Theralase Technologies Inc.'s operating margin compare with similar companies?
Theralase Technologies Inc.'s operating margin (-474.33%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.